Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic Acid for Prevention of Vancomycin-Induced Nephrotoxicity
NCT03921099Phase 4Unknown
- Sponsor
- Ain Shams University
- Start
- Jan 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ascorbic acid in acute kidney injury (AKI), sponsored by Ain Shams University. Status: unknown.
02
Drugs
ascorbic acid
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT03921099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03921099.